Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tilg

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Investigative Dermatology|May 12, 2001
Interleukin-16 supports the migration of Langerhans cells, partly in a CD4-independent wayP Stoitzner, G Ratzinger, F Koch, et al.
Annals of Hematology|November 1, 1993
Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemiaW E Aulitzky, C Peschel, D Desprès, et al.
Journal of Hepatology|September 1, 1993
Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effectsH Tilg, W Vogel, J Tratkiewicz, et al.
Journal of Interferon Research|October 1, 1988
Enhanced serum levels of beta-2-microglobulin, neopterin, and interferon-gamma in patients treated with recombinant tumor necrosis factor-alphaW E Aulitzky, H Tilg, M Herold, et al.
Journal of Interferon Research|August 1, 1989
Acute effects of single doses of recombinant interferon-gamma on blood cell counts and lymphocyte subsets in patients with advanced renal cell cancerW E Aulitzky, W Aulitzky, G Gastl, et al.
Leukemia|June 1, 1989
Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patientsG Gastl, M Werter, B De Pauw, et al.
European Journal of Clinical Investigation|March 4, 2008
Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoformsJ Engl, W Sturm, A Sandhofer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
B lymphocyte-derived IL-16 attracts dendritic cells and Th cellsA Kaser, S Dunzendorfer, F A Offner, et al.
Transplantation|January 15, 1997
Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapyH Schwaighofer, G Oberhuber, H Hebart, et al.
The Journal of Infectious Diseases|June 1, 1991
Human monoclonal antibodies neutralizing cytomegalovirus (CMV) for prophylaxis of CMV disease: report of a phase I trial in bone marrow transplant recipientsW E Aulitzky, T F Schulz, H Tilg, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Investigative Dermatology|May 12, 2001
Interleukin-16 supports the migration of Langerhans cells, partly in a CD4-independent wayP Stoitzner, G Ratzinger, F Koch, et al.
Annals of Hematology|November 1, 1993
Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemiaW E Aulitzky, C Peschel, D Desprès, et al.
Journal of Hepatology|September 1, 1993
Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effectsH Tilg, W Vogel, J Tratkiewicz, et al.
Journal of Interferon Research|October 1, 1988
Enhanced serum levels of beta-2-microglobulin, neopterin, and interferon-gamma in patients treated with recombinant tumor necrosis factor-alphaW E Aulitzky, H Tilg, M Herold, et al.
Journal of Interferon Research|August 1, 1989
Acute effects of single doses of recombinant interferon-gamma on blood cell counts and lymphocyte subsets in patients with advanced renal cell cancerW E Aulitzky, W Aulitzky, G Gastl, et al.
Leukemia|June 1, 1989
Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patientsG Gastl, M Werter, B De Pauw, et al.
European Journal of Clinical Investigation|March 4, 2008
Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoformsJ Engl, W Sturm, A Sandhofer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
B lymphocyte-derived IL-16 attracts dendritic cells and Th cellsA Kaser, S Dunzendorfer, F A Offner, et al.
Transplantation|January 15, 1997
Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapyH Schwaighofer, G Oberhuber, H Hebart, et al.
The Journal of Infectious Diseases|June 1, 1991
Human monoclonal antibodies neutralizing cytomegalovirus (CMV) for prophylaxis of CMV disease: report of a phase I trial in bone marrow transplant recipientsW E Aulitzky, T F Schulz, H Tilg, et al.
Pageof 15